Cardiovascular mortality in the general population versus dialysis: A glass half full or empty?

American Journal of Kidney Diseases

Volumn 58, Issue 1, 2011, Pages 4-6

  Sarnak, Mark J ^a   Foley, Robert N ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b US Renal Data System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CORONARY STENT; EDITORIAL; HEART FAILURE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; ISCHEMIC HEART DISEASE;

ADULT; CARDIOVASCULAR DISEASES; HUMANS; RENAL DIALYSIS;

EID: 79959364770     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.04.004     Document Type: Editorial

References (21)

1. A. Lindner, B. Charra, D.J. Sherrard, and B.H. Scribner Accelerated atherosclerosis in prolonged maintenance hemodialysis N Engl J Med 290 13 1974 697 701
2. M.J. Sarnak, A.S. Levey, and A.C. Schoolwerth Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation 108 17 2003 2154 2169 (Pubitemid 37337595)
3. R.N. Foley, P.S. Parfrey, and M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32 5 1998 S112 S119 (suppl 3)
4. A.S. Levey Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start? Am J Kidney Dis 32 5 1998 S5 S13 (suppl 3)
5. C.A. Herzog, J.Z. Ma, and A.J. Collins Poor long-term survival after acute myocardial infarction among patients on long-term dialysis N Engl J Med 339 12 1998 799 805 (Pubitemid 28447453)
6. S.G. Coca, H.M. Krumholz, A.X. Garg, and C.R. Parikh Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease JAMA 296 11 2006 1377 1384 (Pubitemid 44427424)
7. G.F. Strippoli, J.C. Craig, and F.P. Schena The number, quality, and coverage of randomized controlled trials in nephrology J Am Soc Nephrol 15 2 2004 411 419 (Pubitemid 38140782)
8. M.A. Roberts, K.R. Polkinghorne, S.P. McDonald, and F.L. Ierino Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population Am J Kidney Dis 58 1 2011 64 72
9. D.J. de Jager, D.C. Grootendorst, and K.J. Jager Cardiovascular and noncardiovascular mortality among patients starting dialysis JAMA 302 16 2009 1782 1789
10. M.V. Rocco, G. Yan, and J. Gassman Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration Am J Kidney Dis 39 1 2002 146 153 (Pubitemid 34062507)
11. S.Q. Li, A. Cass, and J. Cunningham Cause of death in patients with end-stage renal disease: assessing concordance of death certificates with registry reports Aust N Z J Public Health 27 4 2003 419 424 (Pubitemid 37038223)
12. T.V. Perneger, M.J. Klag, and P.K. Whelton Cause of death in patients with end-stage renal disease: death certificates vs registry reports Am J Public Health 83 12 1993 1735 1738 (Pubitemid 24009505)
13. J. Xu, D. Kochanek, S. Murphy, and B. Tejada-Vera Deaths: final data for 2007 Natl Vital Stat Rep 58 19 2010 1 136
14. US Renal Data System USRDS 1999 Annual Data Report 1999 The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
15. United States Renal Data System Annual Data Report Am J Kidney Dis 55 suppl 1 2010 S1 S420
16. G.M. Chertow, S.L. Normand, and B.J. McNeil "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency J Am Soc Nephrol 15 9 2004 2462 2468 (Pubitemid 39159347)
17. A.K. Berger, S. Duval, and H.M. Krumholz Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction J Am Coll Cardiol 42 2 2003 201 208 (Pubitemid 36851405)
18. C.S. Fox, P. Muntner, and A.Y. Chen Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry Circulation 121 3 2010 357 365
19. B.C. Fellstrom, A.G. Jardine, and R.E. Schmieder Rosuvastatin and cardiovascular events in patients undergoing hemodialysis N Engl J Med 360 14 2009 1395 1407
20. C. Wanner, V. Krane, and W. Mars Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 3 2005 238 248 (Pubitemid 41058323)
21. P.S. Parfrey, and R.N. Foley The clinical epidemiology of cardiac disease in chronic renal failure J Am Soc Nephrol 10 7 1999 1606 1615 (Pubitemid 29297538)